Categories Earnings, Health Care

Earnings Summary: Baxter International reports higher sales for Q3 2024

Medical device maker Baxter International Inc. (NYSE: BAX) announced financial results for the third quarter of 2024, reporting a modest increase in sales from continuing operations.

  • Sales from continuing operations were $2.70 billion in the September quarter, up 4% on both reported and constant currency basis
  • Third-quarter worldwide sales were $3.85 billion, which includes continuing operations sales of $2.70 billion and discontinued operations sales of $1.15 billion
  • Total Baxter earnings per share were $0.27 in Q3 on a reported basis; adjusted earnings came in at $0.80 per share
  • Q3 net income attributable to the company was $140 million, compared to $2.51 billion in the prior year quarter
  • On an adjusted basis, third-quarter earnings edged down to $0.80 per share from $0.82 per share last year

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

CRWD Earnings: A snapshot of CrowdStrike’s Q4 2025 report

Cybersecurity company CrowdStrike Holdings, Inc. (NASDAQ: CRWD) reported an increase in adjusted profit for the fourth quarter of 2025, reflecting a double-digit growth in revenues. Total revenue increased 25% year-over-year

Key highlights from Campbell’s Company’s (CPB) Q2 2025 earnings results

The Campbell’s Company (NASDAQ: CPB) reported its second quarter 2025 earnings results today. Net sales increased 9% year-over-year to $2.7 billion. Organic sales decreased 2%. Net earnings attributable to The

FL Infographic: Foot Locker Q4 2024 adj. earnings rise despite lower sales

Foot Locker, Inc. (NYSE: FL), a leading footwear and apparel retailer, on Wednesday reported an increase in adjusted profit for the fourth quarter of 2024. Earnings exceeded Wall Street's estimates, while

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close